Literature DB >> 17889184

Correlation between mast cell density and myocardial fibrosis in congestive heart failure patients.

M Batlle1, F Pérez-Villa, A Lázaro, E Garcia-Pras, J Ramirez, J Ortiz, J Orús, M Roqué, M Heras, E Roig.   

Abstract

UNLABELLED: Besides the well-established role of mast cells in allergic reactions as an important source of vasoactive and proinflammatory products, they have been related to tissue fibrosis and remodelling processes. In a heart failure (HF) animal model, mast cells were shown to synthesize transforming growth factor beta1 and basic fibroblast growth factor in myocardial tissue and were localized to an area with fibrosis. Our objective was to quantify mast cell density in left ventricles from patients with congestive heart failure who were candidates for transplantation and to analyze whether they showed a correlation with the fibrosis level of the same area.
METHODS: We obtained myocardial biopsies from 20 patients with end-stage HF secondary to idiopathic dilated cardiomyopathy (iDCM) undergoing heart transplantation and 15 controls (donors without cardiopathy). Mast cells were detected by immunohistochemistry with a human mast cell chymase antibody and fibrosis levels measured with picrosirius red staining of collagen fibrils with later quantification by morphometry.
RESULTS: The patients mean age was 51 +/- 3 years. Fibrosis levels in the myocardial sections from patients with congestive HF was three-fold higher than those in control myocardium (12.41 +/- 1.7% vs 3.98 +/- 0.63%, P < .001). Mast cell density correlated with the collagen fraction and could be fitted to a linear regression curve: collagen fraction = 0.78 + 0.05 mast cell density (n = 33, P < .005, R2 = 0.28).
CONCLUSION: The elevated collagen fraction present in failing hearts may be the cause of increased stiffness and loss of elasticity that is detected in patients with end-stage HF. Due to the mast cells capacity to synthesize vasoactive and fibrogenic products and the correlation between their density and fibrosis levels, they probably play a role in the ventricular remodelling in HF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17889184     DOI: 10.1016/j.transproceed.2007.06.047

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  10 in total

1.  Mast cells and epsilonPKC: a role in cardiac remodeling in hypertension-induced heart failure.

Authors:  Suresh Selvaraj Palaniyandi; Koichi Inagaki; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2008-09-04       Impact factor: 5.000

2.  Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy.

Authors:  Andrew J Boyle; Henry Shih; Joy Hwang; Jianqin Ye; Brian Lee; Yan Zhang; David Kwon; Kristine Jun; Daiwei Zheng; Rich Sievers; Franca Angeli; Yerem Yeghiazarians; Randall Lee
Journal:  Exp Gerontol       Date:  2011-03-03       Impact factor: 4.032

3.  The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions.

Authors:  Weili Zhang; Amanda L Chancey; Huei-Ping Tzeng; Zhenqing Zhou; Kory J Lavine; Feng Gao; Natarajan Sivasubramanian; Philip M Barger; Douglas L Mann
Journal:  Circulation       Date:  2011-10-24       Impact factor: 29.690

Review 4.  Role of inflammatory cells in fibroblast activation.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  J Mol Cell Cardiol       Date:  2015-11-20       Impact factor: 5.000

5.  Substance P-mediated cardiac mast cell activation: An in vitro study.

Authors:  Scott P Levick; Gregory L Brower; Joseph S Janicki
Journal:  Neuropeptides       Date:  2019-01-08       Impact factor: 3.286

6.  Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.

Authors:  Cecilia K Andersson; Annika Andersson-Sjöland; Michiko Mori; Oskar Hallgren; Annie Pardo; Leif Eriksson; Leif Bjermer; Claes-Göran Löfdahl; Moises Selman; Gunilla Westergren-Thorsson; Jonas S Erjefält
Journal:  Respir Res       Date:  2011-10-20

7.  The cardiac repair benefits of inflammation do not persist: evidence from mast cell implantation.

Authors:  Zhengbo Shao; Mansoreh Nazari; Lily Guo; Shu-Hong Li; Jie Sun; Shi-Ming Liu; Hui-Ping Yuan; Richard D Weisel; Ren-Ke Li
Journal:  J Cell Mol Med       Date:  2015-10-16       Impact factor: 5.310

Review 8.  Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure.

Authors:  Tong Liu; Deli Song; Jianzeng Dong; Pinghui Zhu; Jie Liu; Wei Liu; Xiaohai Ma; Lei Zhao; Shukuan Ling
Journal:  Front Physiol       Date:  2017-04-24       Impact factor: 4.566

Review 9.  Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention.

Authors:  Stephanie A Legere; Ian D Haidl; Jean-François Légaré; Jean S Marshall
Journal:  Front Immunol       Date:  2019-03-28       Impact factor: 7.561

10.  Identification of Potential Gene Interactions in Heart Failure Caused by Idiopathic Dilated Cardiomyopathy.

Authors:  Huijuan Huang; Beibei Luo; Boqun Wang; Qianwen Wu; Yuming Liang; Yan He
Journal:  Med Sci Monit       Date:  2018-10-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.